[The in vitro effect of recombinant human growth hormone on lymphocyte and granulocyte function in healthy and uremic children]. 1998

B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
Semmelweis Orvostudományi Egyetem, Budapest.

The aim of the study was to establish the effect of GH on immune functions in 22 healthy and in 11 uremic children, in vitro. Oxydative burst of granulocyte in the presence of GH measured by chemiluminescence and lymphoblast proliferation to GH and lectin stimuli were studied. Gene expression of GH receptor was analyzed with reverse transcriptase polymerase chain reaction (RT-PCR) method. The metabolic burst of granulocytes individually differed, specially in the chronic renal failure (CRF) group (60%) showed rather dose and time-dependent increase, the GH had only a priming effect. In 59% of the healthy children the GH stimulated the lympho-proliferative response itself or interaction with the lectin (ANOVA-test) and increased the spontaneous lymphoproliferation in 45% of the uremic patients. The GH receptor mRNA expression differed in the childrens lymphocytes, showing no correlation with the effect of GH on lymphoproliferation. The GH has a cytokine-like role in the regulation of the human immune system, and the GH treatment in uremic children is rather stimulating on immune functions.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
August 1998, Immunology letters,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
November 2000, The Journal of veterinary medical science,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
June 1989, Acta endocrinologica,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
July 1981, Scandinavian journal of haematology,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
January 2013, Pediatric cardiology,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
February 2004, International journal of hematology,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
November 1997, Zhonghua nei ke za zhi,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
November 1989, Kidney international. Supplement,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
June 1990, The Journal of clinical endocrinology and metabolism,
B Dérfalvi, and P Sallai, and K Német, and C Szalai, and E Kenesei, and T Tulassay, and A Falus
February 1994, Clinical nephrology,
Copied contents to your clipboard!